As of 2025-07-09, the Net Margin of Inhibikase Therapeutics Inc (IKT) is -7304.7%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -7304.7% |
2023-12-31 | -7304.8% |
2022-12-31 | -15041.7% |
2021-12-31 | -477.1% |
2020-12-31 | -407.1% |
2019-12-31 | -510.7% |
2018-12-31 | -53.2% |
2017-12-31 | -21.4% |
2016-12-31 | -64.9% |
- |